News / Health

Novel Gene Therapy Reverses Heart Disease in Animals

Plastinated human heart on display at the European Society of Cardiology meeting, Amsterdam, Sept. 2, 2013.
Plastinated human heart on display at the European Society of Cardiology meeting, Amsterdam, Sept. 2, 2013.
Jessica Berman
Researchers are poised to begin human clinical trials of a novel gene therapy to treat a major cause of heart disease by shrinking enlarged hearts in order to improve blood flow and cardiac function.
 
Heart failure, a leading cause of illness and death worldwide, is caused by a weakening and enlarging of the heart as it works harder to pump enough blood to the rest of the body. A heart attack, untreated high blood pressure or clogged coronary arteries can lead to the condition, which kills most people die within five years of diagnosis.
 
People with heart failure lack a fully functioning gene called SUMO-1, which helps to regulate the calcium that cycles in and out of cells in the ventricles, which pump blood to the body.
 
In experiments with pigs with heart failure, cardiologist Roger Hajjar at Mount Sinai School of Medicine in New York discovered a single infusion of the gene SUMO-1 dramatically improved the function of the animals’ hearts.
 
“Regardless of the cause that induced the heart to be big, we were able to reverse that,” he said.
 
Hajjar's research team at the Cardiovascular Research Center at Icahn School of Medicine has discovered another gene called SERCA2, which also regulates the movement of calcium in heart cells. Their human trials of replacement gene therapy with SERCA2 are showing similar results to the SUMO-1 animal experiments.
 
Hajjar believes infusing both genes simultaneously into cardiac failure patients might double the benefit.
 
“Since we’ve had the experience with SERCA2, we know pretty much the path toward clinical trials from discovery to the bedside," he said. "We feel that within a couple of years, we should be able to take this program forward in terms of gene therapy in patients.”
 
The therapy involving SUMO-1 and SERCA2 uses a harmless cold virus to deliver the genes into the heart.
 
An article on gene therapy for heart failure is published in the journal Science Translational Medicine.

You May Like

Kurdish Party Pushes Political Gamble to Run in Turkey Poll

HDP announces it will run as political party instead of fielding independent candidates in June election, but faces tough 10 percent threshold More

Twitter Targets Islamic State

New research shows suspending Twitter accounts of Islamic State, its supporters has been effective; group, its backers are facing 'significant pressure,' says terrorism expert More

Video Former Sudan 'Lost Boy' Becomes Chess Master in NYC

Majur Juac made the leap from being a refugee in Africa to a master chess champion in US, where he shares his expertise with students More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Super Bowl Ads Compete for Eyes on TV, Webi
X
January 29, 2015 9:58 AM
Super Bowl Sunday (Feb. 1) is about more than just the NFL's American football championship and big parties to watch the game. Viewers also tune in for the world famous commercials that send Facebook and Twitter abuzz. Daniela Schrier reports on the social media rewards for America’s priciest advertising.
Video

Video Super Bowl Ads Compete for Eyes on TV, Web

Super Bowl Sunday (Feb. 1) is about more than just the NFL's American football championship and big parties to watch the game. Viewers also tune in for the world famous commercials that send Facebook and Twitter abuzz. Daniela Schrier reports on the social media rewards for America’s priciest advertising.
Video

Video Theologians Cast Doubt on Morality of Drone Strikes

In 2006, stirred by photos of U.S. soldiers mistreating Iraqi prisoners, a group of American faith leaders and academics launched the National Religious Campaign Against Torture. It played an important role in getting Congress to investigate, and the president to ban, torture. VOA's Jerome Socolovsky reports.
Video

Video Freedom on Decline Worldwide, Report Says

The state of global freedom declined for the ninth consecutive year in 2014, according to global watchdog Freedom House's annual report released Wednesday. VOA's William Gallo has more.
Video

Video As Ground Shifts, Obama Reviews Middle East Strategy

The death of Saudi Arabia’s king, the collapse of a U.S.-friendly government in Yemen and a problematic relationship with Israel’s leadership are presenting a new set of complications for the Obama administration and its Middle East policy. Not only is the U.S. leader dealing with adversaries in Iran, the Islamic State and al-Qaida, but he is now juggling trouble with traditional allies, as White House correspondent Luis Ramirez reports.
Video

Video MRI Seems to Help Diagnose Prostate Cancer, Preliminary Study Shows

Just as with mammography used to detect breast cancer, there's a lot of controversy about tests used to diagnose prostate cancer. Fortunately, a new study shows doctors may now have a more reliable way to diagnose prostate cancer for high risk patients. More from VOA's Carol Pearson.
Video

Video Smartphones About to Make Leap, Carry Basic Senses

Long distance communication contains mostly sounds and pictures. For now. But scientists in Britain say they are close to creating additions for our smartphones that will make it possible to send taste, smell and even a basic touch. VOA’s George Putic reports.
Video

Video NASA Monitors Earth’s Vital Signs From Space

The U.S. space agency, NASA, is wrapping up its busiest 12-month period in more than a decade, with three missions launched in 2014 and two this month, one in early January and the fifth scheduled for January 29. As VOA’s Rosanne Skirble reports, the instruments being lifted into orbit are focused on Earth’s vital life support systems and how they are responding to a warmer planet.
Video

Video Saved By a Mistake - an Auschwitz Survivor's Story

Dagmar Lieblova was 14 when she arrived at Auschwitz in December 1943, along with her entire Czech Jewish family. All of them were to die there, but she was able to leave after several months due to a bureaucratic mix-up which saved her life. Now 85, with three children and six grandchildren, she says she has a feeling of victory. This report by Ahmad Wadiei and Farin Assemi, of RFE/RL's Radio Farda is narrated by RFE’s Raymond Furlong.

Circumventing Censorship

An Internet Primer for Healthy Web Habits

As surveillance and censoring technologies advance, so, too, do new tools for your computer or mobile device that help protect your privacy and break through Internet censorship.
More

All About America

AppleAndroid